Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13,722,662
+$1,184,712 QoQ
Shares Held
27,626
-1.6% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#316
of 1,742 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CIBC WORLD MARKET INC. holds $65,253,987 across 30 Biotechnology names. VRTX ranks #2 (21.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
|
514,764 | $14,140,567 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
27,626 | $13,722,662 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
21,806 | $13,596,913 | |
| 4 | RPRX |
Royalty Pharma plc
|
82,547 | $4,628,410 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
14,093 | $2,639,337 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,221 | $2,173,737 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
75,783 | $1,683,140 | |
| 8 | ASND |
Ascendis Pharma A/S
|
6,156 | $1,641,928 |
All Filings in VRTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,722,662 | 27,626 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $12,537,950 | 28,078 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,687,176 | 8,133 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,225,547 | 8,236 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $13,709,488 | 30,794 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,022,617 | 14,485 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,230,977 | 15,473 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $6,078,130 | 13,069 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,290,691 | 13,421 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $4,922,903 | 11,777 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,227,993 | 10,391 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,862,943 | 8,233 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,607,909 | 13,094 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $828,634 | 2,630 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,088,989 | 3,771 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $976,328 | 3,372 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,216,205 | 4,316 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,728,143 | 6,622 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $858,416 | 3,909 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $292,895 | 1,363 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $233,976 | 990 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $699,348 | 2,570 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $757,418 | 2,609 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,264,301 | 17,921 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||